34 results
Page 2 of 2
8-K
EX-99.1
rkhi14ttgc1m
13 Oct 22
Invivyd Appoints Fred Driscoll as Interim Chief Financial Officer and Announces Resource Reallocation to Maximize Integrated Discovery
4:16pm
S-3
m2b1 hkkk1ce
28 Sep 22
Shelf registration
5:08pm
8-K
EX-99.3
eza1ah
12 Sep 22
Adagio Therapeutics Announces Corporate Name Change to Invivyd
7:46am
8-K
EX-99.2
x9qi5y
12 Sep 22
Adagio Therapeutics Announces Corporate Name Change to Invivyd
7:46am
8-K
EX-99.1
8hfz85zutj7uxstm2rtj
12 Sep 22
Adagio Therapeutics Announces Corporate Name Change to Invivyd
7:46am
10-K
pz7z smkb
31 Mar 22
Annual report
8:18am
8-K
EX-99.1
7eiod9n5
14 Dec 21
Adagio Therapeutics Reports Reduction in In Vitro Neutralizing Activity of ADG20 Against Omicron SARS-CoV-2 Variant
9:10am
8-K
EX-99.1
r7q9n hqw9
29 Nov 21
Regulation FD Disclosure
8:23am
8-K
s7uhg9azbyijdg03ai
29 Nov 21
Regulation FD Disclosure
8:23am
424B4
iy7zbp2py5m4p
6 Aug 21
Prospectus supplement with pricing info
4:54pm
S-1/A
vkrlmvt1f0z7hv1hd4v
2 Aug 21
IPO registration (amended)
6:20am
S-1
s9wfystcan8r0f
16 Jul 21
IPO registration
4:56pm
DRS/A
8w800g0bsx9vttq n0bh
28 Jun 21
Draft registration statement (amended)
12:00am
DRS
eg8znou wcg
21 May 21
Draft registration statement
12:00am